1-4 of 4
Lindsay A.M. Rein, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Trial of Incorporating Natural Killer (K-NK) Cells for Patients with Chronic Myeloid Leukemia (CML) and Molecular Residual Disease after Tyrosine Kinase Inhibitor (TKI) Therapy

Lindsay A.M. Rein, MD, David A Rizzieri, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 5.
https://doi.org/10.1182/blood-2020-142062
Published: 2020
Journal Articles

Clinical Outcomes of Microtransplantation for Older Adults with Acute Myeloid Leukemia

Anthony D. Sung, MD, Carlos M. de Castro, MD, Thomas W. LeBlanc, MD MA, Gwynn D. Long, MD, Donna B. Adams, NP, Danielle M. Brander, MD, Sandeep Dave, MD, Louis F. Diehl, MD, Phuong Linh Doan, MD, Therese Hennig, PA, Yubin Kang, MD, Matthew S. McKinney, MD, Lindsay A.M Rein, MD, Dorothy A. Sipkins, MD, Yiping Yang, MD PhD, Nelson J. Chao, MDM.B.A, David A. Rizzieri, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3853.
https://doi.org/10.1182/blood.V130.Suppl_1.3853.3853
Published: 2017
Journal Articles

β-arrestin2 Is Necessary for Development of MPLW515L Mutant Primary Myelofibrosis

Lindsay A.M. Rein, MD, James W. Wisler, MD, Barbara S. Theriot, BS, Li-Yin Huang, PhD, Richard T. Premont, PhD, Robert J. Lefkowitz, MD
Journal: Blood
Blood (2015) 126 (23): 486.
https://doi.org/10.1182/blood.V126.23.486.486
Published: 2015
Journal Articles

Targeting β-arrestin2 Enhances Survival in a Murine Model of Chronic Myeloid Leukemia

Lindsay A.M. Rein, MD, Minyong Chen, PhD, Barbara S. Theriot, BS, James W. Wisler, MD, Laura M. Wingler, PhD, Richard T. Premont, PhD, Wei Chen, PhD, Julia K.L. Walker, PhD, Robert J. Lefkowitz, MD
Journal: Blood
Blood (2013) 122 (21): 857.
https://doi.org/10.1182/blood.V122.21.857.857
Published: 2013